title: IGF1R signaling is a therapeutic target in ALK fusion-positive lung cancer.
mesh_terms: D000077548:Anaplastic Lymphoma Kinase; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D017526:Receptor, IGF Type 1; D017451:Receptors, Somatomedin / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: C000597236:IGF1R protein, human; D017451:Receptors, Somatomedin; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D020794:Receptor Protein-Tyrosine Kinases; D017526:Receptor, IGF Type 1